Proteins and Peptides

23 Jan 2008 Human Genome Sciences Modifies Dosing In Achieve Trials of Albuferon(R)
23 Jan 2008 DIREVO to collaborate with MedImmune on therapeutic protease for the treatment of CNS diseases
23 Jan 2008 Bayer HealthCare Pharmaceuticals (BAY) Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation
22 Jan 2008 Tercica initiates phase II clinical trial with next-generation growth hormone product for the treatment of short stature
22 Jan 2008 Ambrilia Reports Positive Phase III Preliminary Results Showing the Safety and Efficacy of its Prolonged-Release Formulation of Octreotide
22 Jan 2008 Oramed Pharmaceuticals Commences Phase 1B Clinical Trials
22 Jan 2008 Vyteris Announces First Successful Non-Invasive Delivery of Peptide Using Smart Patch Technology
22 Jan 2008 ImaRx and Microbix sign Letter of Intent to manufacture and further develop the FDA-approved clot-dissolving drug, Abbokinase(R)
22 Jan 2008 Protalix Biotherapeutics Extends Research Agreement With Yissum Ltd. Based on Promising Acetylcholinesterase Program Results in Animal Study
18 Jan 2008 Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer
17 Jan 2008 FDA Approves ZymoGenetics' RECOTHROM(TM) Thrombin, topical
17 Jan 2008 Adherex Announces Phase IIb Expansion of ADH-1 Combination Study in Melanoma
16 Jan 2008 Pfizer and Scil Finalize Agreement for Novel Cartilage Growth Factor
15 Jan 2008 Protox Initiates Phase 2 Prostate Cancer Study
15 Jan 2008 Alfacell Corporation Licenses ONCONASE(R) U.S. Commercial Rights to Strativa Pharmaceuticals
15 Jan 2008 Kamada Announces Successful Completion of Phase I Studies with Aerosolized AAT for the Treatment of Lung Diseases
15 Jan 2008 Molecular Partners AG collaborates with Centocor Research & Development, Inc.
14 Jan 2008 Schering-Plough Reports Top-Line Results of the IDEAL Study
14 Jan 2008 Novo Nordisk refocuses its activities within inhaled insulin and discontinues the development of AERx(R)
14 Jan 2008 ARTES and Minapharm sign long-term strategic development agreement
14 Jan 2008 King Pharmaceuticals Reports FDA Approval Of Revised Labeling Regarding Purity Of THROMBIN-JMI(R)
14 Jan 2008 Three Rivers Pharmaceuticals®, LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals
13 Jan 2008 New published data show otoprotective effect of AM-111 in case of inner ear inflammatory responses (acute labyrinthitis)
11 Jan 2008 Jerini Announces Collaboration Agreement with Baxter to Develop Novel Peptide for Use in Therapeutic Protein Purification
11 Jan 2008 LFB Biotechnologies to Collaborate With GTC Biotherapeutics on Coagulation Factor IX Program

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up